Overall, GLP-1 and GLP-1RAs (as shown in Figure 2) can improve lung function, and airway remodeling, reduce mucus secretion, reduce disease risk and mortality through a variety of pathways, and may hold potential promise in the treatment of airway disease, 80 but GLP-1RAs are not approved for the treatment of COPD, so further studies are needed to confirm this
Around a third of people not already using GLP-1 medications (32%) said they would like to lose weight but still are not planning to begin using GLP-1s
In Handbook of Methods for Oxygen Radical Research (ed
doi:10.3748/wjg.v28.i35.5090
It specializes in weight management medications, wellness injections, and at-home health services
In one study, off-label use was one of the top factors in adverse event reports about semaglutide